Government of India has brought 18 more drugs under price control. Drugs used to treat cancer, inflammation, infections, and others to make life saving medicines affordable in the country.
National Pharmaceutical Pricing Authority (NPPA) the drug pricing regulator has fixed/revised the prices in respect of 39 formulation packs. Prices of formulations including Diclofenac Sodium, Clotrimazole, Mesalamine, Omeprazole+Domperidone and Vancomycin have been fixed.
The latest move of the government will impact various pharmaceutical companies, including Abbott Healthcare, Cipla, Cadila Pharmaceuticals, Dr Reddy’s Laboratories and Torrent Pharma.
Leave a Reply